Clinical Trial Update: Safety and Tolerability of Oral CM082 in Patients With wAMD [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and tolerability of oral CM082 in patients with age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• CM082

Snippet

Sponsor: AnewPharma | Conditions: Age-Related Macular Degeneration | Phase 2 | Status: UNKNOWN